A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
Grandfather and Grandson Complete 5,200km Ride for MND as Bowral Homecoming Nears
After battling relentless headwinds, freezing mornings and road trains on narrow single-lane roads, 82-year-old Bob Montgomery and his 18-year-old gra...
Thank You Deidree
We’d like to give a heartfelt thank you to Deidree Jones, who has been supporting MND NSW for over 25 years!Deidree has been a member of MND NSW since...
82-year-old Grandfather And Grandson Pedal Towards Bowral Finish In Epic Ride For MND
Southern Highlands local Bob Montgomery, 82, and his grandson Tom Malcolm, 18, are closing in on the final stages of their epic 5,200 kilometre r...
29km for 29 years of MND – Cynthia’s Story
For Cynthia Greentree, getting out and about during the week usually involves a good cause.Cynthia has lived with MND for 29 years, and this month she...